Phytochemicals as Potential Inhibitors of Advanced Glycation End Products: Health Aspects and Patent Survey
- PMID: 34053432
- DOI: 10.2174/2212798412666210528130001
Phytochemicals as Potential Inhibitors of Advanced Glycation End Products: Health Aspects and Patent Survey
Abstract
Background: The glycation of proteins and lipids synthesizes the advanced glycation end products (AGEs), i.e., substances that irreversibly damage macromolecules present in tissues and organs, which contribute to the impairment of biological functions. For instance, the accumulation of AGEs induces oxidative stress, the inflammatory responses, and consequently the on set/worsening of diseases, including obesity, asthma, cognitive impairment, and cancer. There is a current demand on natural and low-cost sources of anti-AGE agents. As a result, food phytochemicals presented promising results to inhibit glycation and consequently, the formation of AGEs.
Objective: Here we describe how the AGEs are present in food via Maillard reaction and in organs via natural aging, as well as the effects of AGEs on the worsening of diseases. Also we described the methods used to detect AGEs in samples, and the current findings on the use of phytochemicals (phenolic compounds, phytosterols, carotenoids, terpenes and vitamins) as natural therapeuticals to inhibit health damages via inhibition of AGEs in vitro and in vivo.
Methods: This manuscript reviewed publications available in the PubMed and Science Direct databases dated from the last 20 years on the uses of phytochemicals for the inhibition of AGEs. Recent patents on the use of anti-AGEs drugs were reviewed with the use of Google Advanced Patents database.
Results and discussion: There is no consensus about which concentration of AGEs in blood serum should not be hazardous to the health of individuals. Food phytochemicals derived from agroindustry wastes, including peanut skins, and the bagasses derived from citrus and grapes are promising anti-AGEs agents via scavenging of free radicals, metal ions, the suppression of metabolic pathways that induces inflammation, the activation of pathways that promote antioxidant defense, and the blocking of AGE connection with the receptor for advanced glycation endproducts (RAGE).
Conclusion: Phytochemicals derived from agroindustry are promising anti-AGEs, which can be included to replace synthetic drugs to inhibit AGE formation, and consequently to act as therapeutical strategy to prevent and treat diseases caused by AGEs, including diabetes, ovarian cancer, osteoporosis, and Alzheimer's disease.
Keywords: Maillard reaction; advanced glycation end products; antiglycant; antioxidant.; bioactive compounds; biowastes.
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
-
The Development of Maillard Reaction, and Advanced Glycation End Product (AGE)-Receptor for AGE (RAGE) Signaling Inhibitors as Novel Therapeutic Strategies for Patients with AGE-Related Diseases.Molecules. 2020 Nov 27;25(23):5591. doi: 10.3390/molecules25235591. Molecules. 2020. PMID: 33261212 Free PMC article. Review.
-
Dietary natural products as a potential inhibitor towards advanced glycation end products and hyperglycemic complications: A phytotherapy approaches.Biomed Pharmacother. 2021 Dec;144:112336. doi: 10.1016/j.biopha.2021.112336. Epub 2021 Oct 19. Biomed Pharmacother. 2021. PMID: 34678719 Review.
-
Phytochemicals Against Advanced Glycation End Products (AGEs) and the Receptor System.Curr Pharm Des. 2017;23(8):1135-1141. doi: 10.2174/1381612822666161021155502. Curr Pharm Des. 2017. PMID: 27774900 Review.
-
Inhibition of advance glycation end products formation, gastrointestinal digestion, absorption and toxicity: A comprehensive review.Int J Biol Macromol. 2023 Sep 30;249:125814. doi: 10.1016/j.ijbiomac.2023.125814. Epub 2023 Jul 13. Int J Biol Macromol. 2023. PMID: 37451379 Review.
-
Inhibitors of Advanced Glycation End Product (AGE) Formation and Accumulation.Handb Exp Pharmacol. 2021;264:395-423. doi: 10.1007/164_2020_391. Handb Exp Pharmacol. 2021. PMID: 32809100
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Research Materials